EIF4A3 Promotes Cell Proliferation via CDC5L Upregulation in Human Breast Cancer Cells.

IF 3.3 3区 医学 Q2 ONCOLOGY
Journal of Cancer Pub Date : 2025-03-03 eCollection Date: 2025-01-01 DOI:10.7150/jca.108895
Miao Zhang, Yuchen Xie, Shaoran Song, Ruiqi Wang, He Chen, Yazhao Li, Jie Liu, Juan Li, Yina Jiang, Peijun Liu, Bo Wang
{"title":"EIF4A3 Promotes Cell Proliferation via CDC5L Upregulation in Human Breast Cancer Cells.","authors":"Miao Zhang, Yuchen Xie, Shaoran Song, Ruiqi Wang, He Chen, Yazhao Li, Jie Liu, Juan Li, Yina Jiang, Peijun Liu, Bo Wang","doi":"10.7150/jca.108895","DOIUrl":null,"url":null,"abstract":"<p><p>Breast cancer is one of the most common diseases affecting women's health. While research on breast cancer has made progress in recent years, it remains a major health concern. Studies have shown that the translation initiation factor EIF4A3 is closely related to the occurrence and development of tumors, but the specific mechanism is still unclear. In this study, we aimed to explore the specific molecular mechanism of EIF4A3 in promoting the malignant process of breast cancer <i>in vivo</i> and <i>in vitro</i>. Our results showed that the expression of EIF4A3 was significantly upregulated in breast cancer, and overexpression of EIF4A3 could accelerate the growth of breast cancer cells. RIP-seq and RIP-RT-qPCR analyses indicated that EIF4A3 can bind to the mRNA of CDC5L and influence its expression. From the catRAPID we predicted that EIF4A3-protein could bind to CDC5L by the 5705-5954 region of CDC5L-mRNA. CDC5L was the downstream effector of EIF4A3. These results suggested that the EIF4A3-CDC5L axis promotes the proliferation of breast cancer cells. This study provides a theoretical basis for understanding the role of EIF4A3 in the malignant process of breast cancer.</p>","PeriodicalId":15183,"journal":{"name":"Journal of Cancer","volume":"16 6","pages":"1958-1970"},"PeriodicalIF":3.3000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905404/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7150/jca.108895","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Breast cancer is one of the most common diseases affecting women's health. While research on breast cancer has made progress in recent years, it remains a major health concern. Studies have shown that the translation initiation factor EIF4A3 is closely related to the occurrence and development of tumors, but the specific mechanism is still unclear. In this study, we aimed to explore the specific molecular mechanism of EIF4A3 in promoting the malignant process of breast cancer in vivo and in vitro. Our results showed that the expression of EIF4A3 was significantly upregulated in breast cancer, and overexpression of EIF4A3 could accelerate the growth of breast cancer cells. RIP-seq and RIP-RT-qPCR analyses indicated that EIF4A3 can bind to the mRNA of CDC5L and influence its expression. From the catRAPID we predicted that EIF4A3-protein could bind to CDC5L by the 5705-5954 region of CDC5L-mRNA. CDC5L was the downstream effector of EIF4A3. These results suggested that the EIF4A3-CDC5L axis promotes the proliferation of breast cancer cells. This study provides a theoretical basis for understanding the role of EIF4A3 in the malignant process of breast cancer.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Cancer
Journal of Cancer ONCOLOGY-
CiteScore
8.10
自引率
2.60%
发文量
333
审稿时长
12 weeks
期刊介绍: Journal of Cancer is an open access, peer-reviewed journal with broad scope covering all areas of cancer research, especially novel concepts, new methods, new regimens, new therapeutic agents, and alternative approaches for early detection and intervention of cancer. The Journal is supported by an international editorial board consisting of a distinguished team of cancer researchers. Journal of Cancer aims at rapid publication of high quality results in cancer research while maintaining rigorous peer-review process.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信